QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion

Pharmaceutical Development and Technology

Volumn 16, Issue 3, 2011, Pages 219-227

  Sammour, Omaima A ^a   Hammad, Mohammed A ^b   Zidan, Ahmed S ^b,c,e   Mowafy, Ayman G ^d  

^a Ain Shams University   (Egypt)

^b Zagazig University   (Egypt)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d Nile Company for Pharmaceuticals and Chemical Industries   (Egypt)

^e Building 64 ^*  (United States)

Author keywords

factorial design; Indomethacin; polyvinyl pyrrolidone; rapid disintegrating tablets; solid dispersion

Indexed keywords

CROSCARMELLOSE SODIUM; DISINTEGRATING AGENT; DRUG CARRIER; INDOMETACIN; POLYMER; POVIDONE;

ARTICLE; DIFFRACTION; DISPERSION; DISSOLUTION; DRUG DESIGN; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; FACTORIAL DESIGN; HARDNESS; INFRARED RADIATION; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SOLID; SPECTROSCOPY; STATISTICS; X RAY; X RAY DIFFRACTION;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG STABILITY; HARDNESS; HUMANS; INDOMETHACIN; KINETICS; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 79955693007     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837451003592209     Document Type: Article

References (24)

1. Simonelli AP, Mehta SC, Higuchi WI. Dissolution rates of high energy poly (vinylpyrrolidone) (PVP)-sulfathiazole co-precipitates. J Pharm Sci. 1969;58:538-511.
2. Simonelli AP, Mehta SC, Higuchi WI. Dissolution rates of high energy sulfathiazole-povidone coprecipitates. II: Characterization of form of drug controlling its dissolution rates via solubility studies. J Pharm Sci 1976;65:355-356.
3. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-13.
4. Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method. Int J Pharm 2004;14:187-188.
5. Asada M, Takahashi H, Okamoto H, Tanino H, Danjo K. Theophylline particle design using chitosan by the spray drying. Int J Pharm 2004;270:167-167.
6. Esnaashari S, Javadzadeh Y, Batchelor HK, Conway BR. The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems. Int J Pharm 2005;292:227-230. (Pubitemid 40255804)
7. Van den Mooter G, Augustijns P, Blaton N, Kinget R. Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 1998;164:67-13.
8. European Pharmacopoeia 4.1, 2002. Strasbourg, France.
9. Mallet L. Caring for the elderly patient. J Am Pharm 1996; Assoc. 628.
10. Dobetti L. Fast melting tablets: Developments and technologies. Pharm Technol Drug Deliv 2001;44-46.
11. FDA guidance for industry, orally disintegrating tablets. April, 2007. Accessed from the website: http://www.fda.gov/cder/guidance /index.htm.
12. Yu LX. Pharmaceutical quality by design: Product and process development, understanding and control. Pharm Res 2008;25:781-791.
13. McKenzie P, Kiang S, Tom J, Rubin AE, Futran M. Can pharmaceutical process development become high tech. AIChE 2006;52:3990-3994. (Pubitemid 44935191)
14. Pignatello R, Ferro M, Guidi G, Salemi G, Vandelli MA, Guccione S, Geppi M, Forte C, Puglisi G. Preparation, characterization and photosensitivity studies of solid dispersion difunisal and Eudraget RS 100 and RL 100. Int J Pharm 2001;218:27-42.
15. Sammour OA, Hammad MA, Megrab N.A, Zidan AS. Formulation and Optimization of Mouth Dissolve Tablets Containing Rofecoxib Solid Dispersion. AAPS PharmSciTech 2006;7,2: Article 55.
16. Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech 2004;5:Article 36.
17. Fini A, Bergamante V, Ceschel GC, Ronchi C, Moraes CAF. Fast dispersible/slow releasing ibuprofen tablets. Eur J Pharmaceut Biopharmaceut 2008;69(1):335-336.
18. Kornblum SS, Stoopak SB. A new tablet disintegrating agent: Cross-linked polyvinyl-pyrrolidone. J Pharm Sci 1973;62:43-46.
19. Nogami H, Nagai T, Fukuoka E, Sonobe T. Disintegration of the aspirin tablets containing potato starch and microcrystalline cellulose in various concentrations. Chem Pharm Bull 1969;17:1450-1455.
20. Grai E, Ghanem AH, Mahmoud H. Studies of the direct compression of pharmaceuticals. Pharm Ind 1984;46:279-283.
21. Gafitanu E, Dumistracel I, Antochi S. Formulations and bioavailability of propylphenazone in lyophilized tablets. Rev Med Chir Soc Nat Iasi 1991;95(1-2):127-134.
22. Fassihi AR. Mechanisms of disintegration and compactibility of disintegrants in a direct compression system. Int J Pharm 1986;32:93-96. (Pubitemid 16038941)
23. List PH, Muazzam UA. Swelling-the driving force behind disintegration. Pharm Ind 1979;41:1075-1077.
24. Ferrero C, Munoz N, Velasco MV, Munoz-Ruiz A, Jimemez-Castellanos MR. Disintegrating efficiency of croscarmellose sodium in a direct compression formulation. Int J Pharm 1997;147:11-21. (Pubitemid 27130061)